Filing Flows › iSpecimen (ISPC) › Q4 2025
iSpecimen (ISPC) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Apr 1, 2026
iSpecimen (ISPC) reported revenue of $52K for the fourth quarter 2025 (Q4 2025), -96% from a year earlier and -51% from the quarter before.
iSpecimen, Q4 2025: revenue $52K (-96% year over year), net loss $5.0M, operating cash flow −$917K. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $52K | -51% | -96% |
| Operating profit | −$2.7M | — | — |
| Net earnings | −$5.0M | — | — |
| Operating cash flow | −$917K | — | — |
What changed
Revenue was $52K in Q4 2025, down 96% year over year and down 51% from the previous quarter.
Operating costs exceeded revenue by $2.7M, an operating margin of -5192.9%. Total costs fell 63% while revenue fell 96%. The quarter ended with a net loss of $5.0M, wider than the previous quarter's $2.8M loss.
Operating cash flow was −$917K. Non-cash charges added back $408K of depreciation and amortization and $2K of share-based compensation. Working capital and other items added $3.7M.
Questions
What was iSpecimen's revenue in the fourth quarter 2025?
iSpecimen (ISPC) reported revenue of $52K for the fourth quarter 2025 (Q4 2025), -96% from a year earlier and -51% from the quarter before.
Source: iSpecimen 10-K on SEC EDGAR.